| I-027 Massinissa Beldjenna Development of a multi-endpoint mechanistic pharmacokinetic-pharmacodynamic model describing CD40 antagonism in autoimmune diseases. Wednesday 10:20-11:50 |
| I-027 Massinissa Beldjenna Development of a multi-endpoint mechanistic pharmacokinetic-pharmacodynamic model describing CD40 antagonism in autoimmune diseases. Wednesday 10:20-11:50 |